CS
EXAS

Credit Suisse’s Exact Sciences EXAS Stock Holding History

Credit Suisse’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-200,000
Closed -$4.72M – 3860
2017
Q1 		$4.72M Buy
+200,000
New +$3.96M ﹤0.01% 1693
2013
Q3 		– Sell
-10,000
Closed -$139K – 4240
2013
Q2 		$139K Buy
+10,000
New +$109K ﹤0.01% 3951

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Credit Suisse's EXAS Position: Q1 2024 in Review

Credit Suisse reduced its Exact Sciences (EXAS) stake by 1.3% in Q1 2024, selling an estimated $804K and leaving 976,932 shares worth $67.5M. The position accounts for 0.06% of the portfolio, ranked #292.

Credit Suisse first reported a position in EXAS in Q2 2013 and has held it in 44 quarters since. The position peaked at $240M in Q1 2021. 626 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Credit Suisse held 976,932 shares of Exact Sciences worth $67.5M as of Q1 2024.
  • Credit Suisse sold 12,712 Exact Sciences shares in Q1 2024, an estimated $804K.
  • Exact Sciences made up 0.06% of Credit Suisse's portfolio in Q1 2024, its #292 holding.
  • Credit Suisse first reported a position in Exact Sciences in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Exact Sciences position peaked at $240M in Q1 2021.
  • 626 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.